INCY Stock Catalyst Calendar

The European Society for Medical Oncology (ESMO) Congress 2026 will be taking place. Location:Madrid -------- Rapid oral session presentation of preliminary efficacy data for INCB123667 with bevacizumab in recurrent epithelial ovarian cancer.

The European Academy of Dermatology and Venereology (EADV) Congress 2026 will be taking place. Location:Vienna Austria -------- Poster presenting comparative efficacy data for 1.5% ruxolitinib cream versus systemic therapies in moderate atopic dermatitis. Location:Vienna Austria -------- Poster presenting 24-week safety and pharmacokinetics results for ruxolitinib cream from the TRuE-AD4 study in adults with moderate atopic dermatitis eligible for systemic therapy. Location:Vienna Austria -------- Poster presenting international survey results (TOPiQAL) describing patient profile and multidimensional burden of atopic dermatitis. Location:Vienna Austria -------- Poster presenting TOPiQAL international study findings on patient treatment preferences in atopic dermatitis using best-worst scaling. Location:Vienna Austria -------- Poster presenting randomized trial and real-world data insights on ruxolitinib cream in moderate atopic dermatitis across disease severity thresholds. Location:Vienna Austria -------- Poster presenting long-term TRuE-AD4 results on patient-reported symptom and quality-of-life outcomes with as-needed use of ruxolitinib cream in adults with moderate atopic dermatitis eligible for systemic therapy. Location:Vienna Austria -------- Poster presenting item-level patient-reported outcome results from TRuE-AD4 evaluating ruxolitinib cream in adults with moderate atopic dermatitis after failure of topical corticosteroids and topical calcineurin inhibitors. Location:Vienna Austria -------- Poster presenting TRuE-AD4 study results on use of ruxolitinib cream to delay or prevent treatment escalation in adults with moderate atopic dermatitis eligible for systemic therapy. Location:Vienna Austria -------- Poster presenting pooled Phase 3 STOP-HS1/STOP-HS2 findings characterizing acne in patients with moderate to severe hidradenitis suppurativa treated with povorcitinib. Location:Vienna Austria -------- Poster presenting pooled Phase 3 STOP-HS1/STOP-HS2 results on clinical patient-reported and biomarker outcomes with povorcitinib in hidradenitis suppurativa patients with high disease burden. Location:Vienna Austria -------- Poster presenting HERALD survey insights on real-world treatment challenges and unmet needs among biologic-experienced European patients with hidradenitis suppurativa. Location:Vienna Austria -------- Poster presenting a real-world claims-based algorithm for identifying moderate to severe prurigo nodularis. Location:Vienna Austria -------- Poster presenting epidemiology treatment patterns and healthcare resource utilization findings for prurigo nodularis in the US and Germany. Location:Vienna Austria -------- Poster presenting exposure-response modeling used to inform Phase 3 dose selection of povorcitinib in nonsegmental vitiligo. Location:Vienna Austria -------- Poster describing development of a prospective regulatory-grade disease registry to characterize real-world care for nonsegmental vitiligo. Location:Vienna Austria -------- Poster presenting quality-of-life and treatment impact findings from an open-label Phase 2 study of ruxolitinib cream in patients with genital vitiligo. Location:Vienna Austria -------- Poster presenting an integrated mixed-effects pharmacokinetics analysis of ruxolitinib cream and implications for safety profile in patients with inflammatory skin diseases.

The Morgan Stanley 24th Annual Global Healthcare Conference will be taking place. Location:virtual -------- Incyte will deliver a corporate presentation as part of an investor healthcare conference; the presentation will be webcast live and available for replay. DCGO: Lee Bienstock will deliver a fireside presentation during the Morgan Stanley 24th Annual Global Healthcare Conference; a webcast will be available via DocGo's investor relations website.

The Cantor Global Healthcare Conference 2026 will be taking place. Location:virtual -------- Incyte will deliver a corporate presentation as part of an investor healthcare conference; the presentation will be webcast live and available for replay.

The 21st Annual Wells Fargo Healthcare Conference will be taking place. Location:virtual -------- Incyte will deliver a corporate presentation as part of an investor healthcare conference; the presentation will be webcast live and available for replay.